Assetmark Inc. Increases Stake in AbbVie, Strengthening Institutiona...

Headlines,Assetmark Inc. raises stake in AbbVie Inc. (NYSE),Institutional investors boost their positions in AbbVie,Strong institutional support for A...

Assetmark Inc. Increases Stake in CVS Health as Institutional Suppor...

Headlines,Assetmark Inc. boosts its stake in CVS Health,Institutional investors continue to increase CVS Health holdings,CVS Health shows significant...

Verdence Capital Advisors Increases Stake in Johnson & Johnson

Headlines,Verdence Capital Advisors boosts its holdings in Johnson & Johnson, signaling continued interest in the healthcare leader.,Other institution...

Positive Earnings Expected at Canopy Growth as Cost Savings Take Eff...

Highlights:,Canopy Growth reports a positive outlook for adjusted EBITDA in upcoming quarters, driven by cost-saving initiatives.,The company’s Q2 fis...

Key Highlights from Iovance Biotherapeutics Inc. Q3 2024 Earnings Ca...

Highlights:,Iovance Biotherapeutics provides an update on its commercial launch of Amtagvi and its revenue guidance.,Key developments include progress...

Wall Street Analysts Express Positive Outlook on AbbVie Stock

Highlights,AbbVie Inc. has seen strong stock performance, outpacing both the broader market and sector indexes.,The company reported better-than-expec...

Baird Sees McKesson Stock Poised for Upside, Driven by US Pharma and...

Highlights:,Baird upgraded McKesson Corporation’s stock from Neutral to Outperform, raising its price target to $688 from $531.,McKesson's strong perf...

Rhythm Pharmaceuticals Inc (RYTM) Discusses Revenue Growth and Globa...

Highlights:,Rhythm Pharmaceuticals reported strong revenue growth in Q3 2024, with total revenues of $33.3 million, marking a 14% quarter-over-quarter...

Wedbush Begins Coverage of Rezolute (RZLT) with Outperform Rating

Highlights:,Wedbush Initiates Coverage:,Wedbush initiated coverage of Rezolute (NasdaqCM: RZLT) on November 5, 2024, with an,Outperform,rating.,Strong...

Revenue Rises to $30M in AnaptysBio Inc. (ANAB) Q3 2024, EPS of -$1....

Highlights:,AnaptysBio's Q3 2024 revenue of $30.0 million significantly exceeded the analyst estimate of $6.87 million, driven by collaboration revenu...

Centene Sees Surge in Call Option Activity and Analyst Adjustments (...

Headlines,Significant call option activity for Centene Corp.,Recent analysts adjust target price for Centene.,Large investors raise their positions in...

CVS Health Co. (NYSE:CVS) Shares Sold by Janney Montgomery Scott LLC...

Highlights:,Janney Montgomery Scott LLC reduced its stake in CVS Health by 24.8% during Q3 2024.,CVS Health’s quarterly revenue increased by 2.6% year...

Select Medical Holdings Announces Dividend with Strong Earnings Outl...

Headlines,Select Medical Holdings Corporation announces a dividend of $0.125 per share.,Projected earnings suggest strong coverage for future distribu...

Understanding Institutional Ownership in Johnson & Johnson

Headlines,Strong institutional ownership influences Johnson & Johnson's stock dynamics,Institutional investors prioritize companies in major indices,T...

Institutional Ownership Holds Key to CVS Health's Future

Headlines,CVS Health’s ownership is dominated by institutional investors, holding 83% of shares.,Recent share value drops may pressure institutional i...

Vertex Pharmaceuticals Inc (VRTX) Q3 2024 Earnings Call Highlights R...

Highlights:,Vertex Pharmaceuticals reports 12% year-over-year revenue growth in Q3 2024, reaching $2.77 billion.,The company increases full-year reven...

Strong Revenue Growth Highlighted in Hologic Inc (HOLX) Q4 2024 Earn...

Highlights:,Hologic Inc. (HOLX) reports a 4.2% year-over-year growth in Q4 2024 total revenue, reaching $987.9 million.,The company demonstrates stron...

Tempus (TEMP) Reports Healthy Q3 2024 Revenue Growth, Expands Testin...

Highlights:,Tempus reports 33% YoY revenue growth to $180.9M, driven by strong data services and genomics unit performance.,The company announces the...

Top 2 pharma stocks to buy amid surge in deadly fungi

Recent data cited by Bloomberg reveals that deadly fungi, including Candida auris, have been spreading globally since the COVID-19 pandemic. Climate c...

Should you buy Viking Therapeutics (VKTX) after today’s spike?

Viking Therapeutics (NASDAQ: VKTX) saw its stock surge over 10% in pre-market trading on November 4, following the release of highly encouraging early...